|
Name |
15-hydroxydecaturin A
|
Molecular Formula | C30H35NO7 | |
IUPAC Name* |
(1R,2S,3'S,6S,7R,10S,12S)-3',10,12-trihydroxy-5,7,11,11-tetramethyl-6'-pyridin-3-ylspiro[13-oxatetracyclo[10.2.2.01,10.02,7]hexadec-4-ene-6,2'-3H-furo[3,2-c]pyran]-4'-one
|
|
SMILES |
CC1=CC[C@H]2[C@]([C@]13[C@H](C4=C(O3)C=C(OC4=O)C5=CN=CC=C5)O)(CC[C@@]6([C@]27CC[C@@](C6(C)C)(OC7)O)O)C
|
|
InChI |
InChI=1S/C30H35NO7/c1-17-7-8-21-26(4,9-11-28(34)25(2,3)29(35)12-10-27(21,28)16-36-29)30(17)23(32)22-20(38-30)14-19(37-24(22)33)18-6-5-13-31-15-18/h5-7,13-15,21,23,32,34-35H,8-12,16H2,1-4H3/t21-,23-,26+,27-,28+,29-,30+/m0/s1
|
|
InChIKey |
IASMJIKTAVKWAG-DOMNMBBASA-N
|
|
Synonyms |
15-hydroxydecaturin A
|
|
CAS | NA | |
PubChem CID | 139584245 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 521.6 | ALogp: | 1.7 |
HBD: | 3 | HBA: | 8 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 118.0 | Aromatic Rings: | 8 |
Heavy Atoms: | 38 | QED Weighted: | 0.468 |
Caco-2 Permeability: | -4.972 | MDCK Permeability: | 0.00001720 |
Pgp-inhibitor: | 0.65 | Pgp-substrate: | 0.963 |
Human Intestinal Absorption (HIA): | 0.085 | 20% Bioavailability (F20%): | 0.862 |
30% Bioavailability (F30%): | 0.884 |
Blood-Brain-Barrier Penetration (BBB): | 0.937 | Plasma Protein Binding (PPB): | 70.93% |
Volume Distribution (VD): | 2.069 | Fu: | 26.34% |
CYP1A2-inhibitor: | 0.107 | CYP1A2-substrate: | 0.955 |
CYP2C19-inhibitor: | 0.197 | CYP2C19-substrate: | 0.717 |
CYP2C9-inhibitor: | 0.381 | CYP2C9-substrate: | 0.014 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.088 |
CYP3A4-inhibitor: | 0.929 | CYP3A4-substrate: | 0.675 |
Clearance (CL): | 8.293 | Half-life (T1/2): | 0.178 |
hERG Blockers: | 0.795 | Human Hepatotoxicity (H-HT): | 0.823 |
Drug-inuced Liver Injury (DILI): | 0.687 | AMES Toxicity: | 0.011 |
Rat Oral Acute Toxicity: | 0.985 | Maximum Recommended Daily Dose: | 0.987 |
Skin Sensitization: | 0.232 | Carcinogencity: | 0.925 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.009 |
Respiratory Toxicity: | 0.985 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002102 | 0.780 | D02STN | 0.293 | ||||
ENC002080 | 0.750 | D06CNP | 0.277 | ||||
ENC002411 | 0.669 | D04GJN | 0.217 | ||||
ENC002410 | 0.591 | D0L2LS | 0.213 | ||||
ENC002412 | 0.588 | D0N0RU | 0.205 | ||||
ENC003423 | 0.534 | D0V4WD | 0.204 | ||||
ENC003422 | 0.511 | D0Z1XD | 0.201 | ||||
ENC002118 | 0.489 | D09HNR | 0.200 | ||||
ENC005020 | 0.394 | D06IIB | 0.195 | ||||
ENC002192 | 0.386 | D0P0HT | 0.195 |